BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.580
-0.040 (-2.47%)
At close: Oct 26, 2026, 4:00 PM EDT
1.540
-0.040 (-2.53%)
After-hours: Oct 26, 2026, 7:26 PM EDT
BioRestorative Therapies Stock Forecast
BRTX's stock price has decreased by -94.97% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, BioRestorative Therapies stock has a consensus rating of "Buy" and an average price target of $160. The average 1-year stock price forecast is 10,026.58% higher than the current stock price, while the lowest is $20 (+1,165.82%) and the highest is $300 (+18,887.34%).
Price Target: $160 (+10,026.58%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BioRestorative Therapies stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Aug '25 | Nov '25 | Feb '26 | Apr '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Oct 6, 2026 |
Financial Forecast
Revenue This Year
310.00K
from 359.70K
Decreased by -13.82%
Revenue Next Year
1.50M
from 310.00K
Increased by 383.87%
EPS This Year
-13.20
from -31.60
EPS Next Year
-10.40
from -13.20
EPS and Forward PE are based on non-GAAP adjusted numbers.